Page last updated: 2024-08-23

brimonidine tartrate and Retinal Degeneration

brimonidine tartrate has been researched along with Retinal Degeneration in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Hu, Y; Liu, J; Lou, X; Zhang, H; Zhao, Y1
Harada, C; Harada, T; Kimura, A; Mitamura, Y; Namekata, K; Semba, K1
Cunha-Vaz, J; Frydkjaer-Olsen, U; Grauslund, J; Peto, T; Simó, R; Soegaard Hansen, R1
Dermon, C; Panagis, L; Prokosch, V; Thanos, S; Volk, GF1
Avilés-Trigueros, M; de Imperial, JM; De la Villa, P; García-Avilés, A; López-Herrera, MP; Mayor-Torroglosa, S; Rodríguez, ME; Vidal-Sanz, M; Villegas-Pérez, MP1
Chowers, I; Farber, MD; Merin, S; Obolensky, A1

Trials

2 trial(s) available for brimonidine tartrate and Retinal Degeneration

ArticleYear
Correlation between Retinal Vessel Calibre and Neurodegeneration in Patients with Type 2 Diabetes Mellitus in the European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR).
    Ophthalmic research, 2016, Volume: 56, Issue:1

    Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Brimonidine Tartrate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Drug Therapy, Combination; Electroretinography; Female; Follow-Up Studies; Hormones; Humans; Jupiter; Male; Middle Aged; Neuroprotective Agents; Ophthalmic Solutions; Prospective Studies; Retinal Degeneration; Retinal Ganglion Cells; Retinal Vessels; Somatostatin; Time Factors; Tomography, Optical Coherence; Treatment Outcome

2016
A pilot study of topical treatment with an alpha2-agonist in patients with retinal dystrophies.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:1

    Topics: Administration, Topical; Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult; Aged; Brimonidine Tartrate; Contrast Sensitivity; Electroretinography; Female; Humans; Male; Middle Aged; Patient Compliance; Pilot Projects; Prospective Studies; Quinoxalines; Retinal Degeneration; Retinal Diseases; Retinitis Pigmentosa; Treatment Outcome; Visual Acuity; Visual Fields

2008

Other Studies

4 other study(ies) available for brimonidine tartrate and Retinal Degeneration

ArticleYear
Polydopamine nanoparticles attenuate retina ganglion cell degeneration and restore visual function after optic nerve injury.
    Journal of nanobiotechnology, 2021, Dec-20, Volume: 19, Issue:1

    Topics: Animals; Brimonidine Tartrate; Cell Survival; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Indoles; Macrophages; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Nitric Oxide Synthase Type II; Optic Nerve Injuries; Polymers; Reactive Oxygen Species; Retina; Retinal Degeneration; Retinal Ganglion Cells; Transcriptome

2021
Brimonidine prevents neurodegeneration in a mouse model of normal tension glaucoma.
    Cell death & disease, 2014, Jul-17, Volume: 5

    Topics: Animals; Brimonidine Tartrate; Excitatory Amino Acid Transporter 3; Female; Glaucoma; Humans; Male; Mice; Mice, Knockout; Protective Agents; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Retinal Degeneration; Retinal Ganglion Cells

2014
Alpha2-adrenergic receptors and their core involvement in the process of axonal growth in retinal explants.
    Investigative ophthalmology & visual science, 2010, Volume: 51, Issue:12

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Autoradiography; Axons; Brimonidine Tartrate; Clonidine; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Fluorescent Antibody Technique, Indirect; Glaucoma; Glial Fibrillary Acidic Protein; Optic Nerve Injuries; Organ Culture Techniques; Platelet Activating Factor; Protein Disulfide-Isomerases; Proteomics; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Laminin; Retina; Retinal Degeneration; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2010
Ischemia results 3 months later in altered ERG, degeneration of inner layers, and deafferented tectum: neuroprotection with brimonidine.
    Investigative ophthalmology & visual science, 2005, Volume: 46, Issue:10

    Topics: Animals; Brimonidine Tartrate; Electroretinography; Female; Ischemia; Ligation; Nerve Degeneration; Neuroprotective Agents; Ophthalmic Artery; Quinoxalines; Rats; Rats, Sprague-Dawley; Retina; Retinal Degeneration; Retinal Ganglion Cells; Retinal Vessels; Superior Colliculi; Time Factors; Visual Pathways

2005